As depicted in Figure 2, treatment with DMC-HA effectively curtailed the augmented migration (Figure 2B) and invasion (Figure 2C) of glioma cells induced by 10 ng/mL TGF-β1. The gene discussed is TGFB1; the disease is central nervous system cancer.